Related Experiment Video
Updated: Aug 7, 2026

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
Published on: May 11, 2018
[Antisense oligonucleotide targeting survivin affects the proliferation and apoptosis of SMMC-7721 cells]
Kejian Pan1, Xiaojing Liu, Chunlei Yang
1Division of Basic Medical Science, Chengdu Medical College, Chengdu 610083, China. pkj6696@yahoo.com.cn
Abstract:
Survivin is a member of inhibitor of apoptosis (IAP) family which has strong ability of antiapoptosis. Survivin is prominently expressed in transformed cell lines and in all the most common human cancers in vivo, but it is undetectable in terminally differentiated adult tissues. We designed a human survivin antisense oligonucleotides. RT-PCR and Western blot clearly showed that survivin mRNA and protein were decreased by this antisense oligonucleotide. The inhibition of SMMC-7721 cell proliferation was demonstrated by MTT assay. The inhibition rate (43.28% +/- 3.65%) was much higher than the inhibition rate (6.76% +/- 0.92%) of the control group. The apoptosis rate (33.68% +/- 2.89%) obtained by transfecting cells with the use of antisense oligonucleotide was higher than the apoptosis rate (14.12% +/- 1.24%) of the control group. And the result of TUNEL revealed that, when SMMC-7721 cells were exposed to homoharringtoine at low concentration and were transfected by antisense oligonucleotide, the apoptosis rate of the cells was significantly higher than that of other control group. These results indicate that antisense oligonucleotide may have the potential for selective tumor therapy in future.
Insights
Antisense oligonucleotides targeting survivin effectively reduced cancer cell proliferation and increased apoptosis. This suggests a potential for selective tumor therapy in the future.
Area of Science:
- Molecular Biology
- Cancer Research
- Apoptosis Regulation
Background:
- Survivin, an inhibitor of apoptosis (IAP) protein, is highly expressed in various human cancers but not in normal adult tissues.
- This differential expression makes survivin a promising target for selective cancer therapies.
Purpose of the Study:
- To design and evaluate the efficacy of a human survivin antisense oligonucleotide.
- To assess the impact of survivin inhibition on cancer cell proliferation and apoptosis.
Main Methods:
- Reverse Transcription Polymerase Chain Reaction (RT-PCR) and Western blot to confirm survivin mRNA and protein reduction.
- MTT assay to measure SMMC-7721 cell proliferation inhibition.
- Flow cytometry and TUNEL assay to quantify apoptosis rates.
Main Results:
- The survivin antisense oligonucleotide significantly decreased survivin mRNA and protein levels in SMMC-7721 cells.
- Cell proliferation was inhibited by 43.28% in the antisense oligonucleotide group compared to 6.76% in the control.
- Apoptosis rates increased to 33.68% with antisense oligonucleotide treatment, significantly higher than the control group's 14.12%.
Conclusions:
- Human survivin antisense oligonucleotides effectively inhibit cancer cell proliferation and induce apoptosis.
- Survivin-targeted antisense oligonucleotides demonstrate potential as a selective therapeutic strategy for human cancers.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

